Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
100
datasets available to search
ShareScore release 0.9.0
Dataset results
100 results for “NMIBC”
ADSTILADRIN (=INSTILADRIN) in Patients With High-Grade, Bacillus Calmette-Guerin (BCG) Unresponsive Non-Muscle Invasive Bladder Cancer (NMIBC)
ClinicalTrials.gov study NCT02773849. IPD Sharing: NO. Countries: 1. Publications: 2.
Intravesical GEM/DOCE for HR BCG-Unresponsive NMIBC
ClinicalTrials.gov study NCT07322263. IPD Sharing: NO. Countries: 1. Publications: 26.
Safety and Pharmacology Study of Atezolizumab Alone and in Combination With Bacille Calmette-Guérin (BCG) in High-Risk Non-Muscle-Invasive Bladder Cancer (NMIBC) Participants
ClinicalTrials.gov study NCT02792192. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Efficacy and Safety of Pembrolizumab (MK-3475) in Combination With Bacillus Calmette-Guerin (BCG) in High-Risk Non-Muscle Invasive Bladder Cancer (HR NMIBC) (MK-3475-676/KEYNOTE-676)
ClinicalTrials.gov study NCT03711032. IPD Sharing: YES. Countries: 29. Publications: 1.
A Study of TAR-200 in Combination With Cetrelimab, TAR-200 Alone, or Cetrelimab Alone in Participants With Non-Muscle Invasive Bladder Cancer (NMIBC) Unresponsive to Intravesical Bacillus Calmette-Gué
ClinicalTrials.gov study NCT04640623. IPD Sharing: YES. Countries: 16. Publications: 1.
Intravesical BCG vs GEMDOCE in NMIBC
ClinicalTrials.gov study NCT05538663. IPD Sharing: NO. Countries: 1. Publications: 1.
Blue Laser -5ala Photodynamic Therapy (PDT) in High-Risk Non-muscle Invasive Bladder Cancer (NMIBC) Patients
ClinicalTrials.gov study NCT05547516. IPD Sharing: Not stated. Countries: 1. Publications: 6.
To Evaluate the Safety, Efficacy, and Pharmacokinetics of Intravesical Instiliations of Disitamab Vedotin in Patients With High-risk Non-muscular Invasive Bladder Cancer (NMIBC) That Express HER2
ClinicalTrials.gov study NCT06378242. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Comparison of BCG RIVM and Russian Strains for Treating Non-Muscle-Invasive Bladder Cancer (NMIBC)
ClinicalTrials.gov study NCT06767982. IPD Sharing: YES. Countries: 1. Publications: 5.
Prognostic Effect of Whether Doing PLND During RC for High-risk NMIBC
ClinicalTrials.gov study NCT05123625. IPD Sharing: NO. Countries: 1. Publications: 25.
Evaluation of a Patient-Reported Symptom Index for NMIBC
ClinicalTrials.gov study NCT03091764. IPD Sharing: NO. Countries: 5. Publications: 1.
Anesthesia Modality and Oncologic Outcomes in High-Risk NMIBC: A Randomized Trial
ClinicalTrials.gov study NCT06982690. IPD Sharing: UNDECIDED. Countries: 1. Publications: 1.
Intravesical Ty21a for the Treatment of Patients With Non-muscle-invasive Bladder Cancer (NMIBC)
ClinicalTrials.gov study NCT03421236. IPD Sharing: NO. Countries: 1. Publications: 1.
Safety of Pre-TURBT Intravesical Instillation of Escalating Doses of TC-3 Gel and MMC in NMIBC Patients
ClinicalTrials.gov study NCT02307487. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Neoadjuvant Short-term Intensive Chemoresection Versus Standard Adjuvant Intravesical Instillations in NMIBC
ClinicalTrials.gov study NCT03348969. IPD Sharing: NO. Countries: 1. Publications: 15.
A Phase I Intravesical PPM Therapy for NMIBC
ClinicalTrials.gov study NCT05519241. IPD Sharing: NO. Countries: 1. Publications: 0.
A Study of Adjuvant Cretostimogene Grenadenorepvec for Treatment of Intermediate Risk NMIBC Following TURBT
ClinicalTrials.gov study NCT06111235. IPD Sharing: NO. Countries: 2. Publications: 1.
Toripalimab ± Sequential Intravesical Gemcitabine-Mitomycin C for BCG-Unresponsive/-Intolerant High-Risk NMIBC: Open-Label Randomized Phase 2 Study
ClinicalTrials.gov study NCT07189793. IPD Sharing: UNDECIDED. Countries: 1. Publications: 6.
Safety and Efficacy of Camrelizumab for High-risk NMIBC Failing BCG Treatment
ClinicalTrials.gov study NCT04706598. IPD Sharing: UNDECIDED. Countries: 1. Publications: 17.
External Validation of Uromonitor as a Biomarker for Optimization of NMIBC Management by the CUETO Group
ClinicalTrials.gov study NCT05864599. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.